Customer perspective:

“We believe V-LAP can slow down deterioration of heart failure, improve patient quality of life and reduce hospitalizations. It will be a game-changer, helping millions of patients. BioT’s medical-cloud platform enhanced Vectorious security through the built-in HIPAA and GDPR regulatory compliance capabilities, accelerated the V-LAP development time, and helped us move faster to clinical trials in Europe. Together with BioT, we can help our patients to take control and manage their disease.”